BN
Brookfield Corporation
BN's fundamentals are strong: its operating margin rose 4 points to 29% and earnings per share grew 87%. At 75x earnings, it's trading in line with its usual 71x. Analysts expect strong earnings growth.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
BN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
BN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like BN.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
BN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $41.64 | — |
| Cheap | 20x | $10.94 | -74% |
| Fair | 71x | $39.79 | -4.4% |
| Current | 75x | $41.64 | — |
| Expensive | 130x | $72.77 | +75% |
Historical ranges are pointers, not guarantees.
BN's PE is in its fair range at 75x. If earnings grow as analysts expect, today's price would be 13x next year's earnings, in its cheap range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
BN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| -- | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for BN, with profitability holding steady.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
BN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $3.22 | +475% |
| Q2 2026 | $0.56 | +87% |
| Q1 2026 | $0.52 | +160% |
| Q4 2025 | $0.49 | +133% |
| Q3 2025 | $0.36 | +13% |
| Q2 2025 | $0.30 | -21% |
| Q1 2025 | $0.20 | -50% |
| Q4 2024 | $0.21 | -49% |
| Q3 2024 | $0.32 | +$0.34 |
BN has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
BN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $19.3B | +6.6% |
| Q1 2026 | $18.4B | +2.5% |
| Q4 2025 | $21.2B | +9% |
| Q3 2025 | $18.9B | -8.3% |
| Q2 2025 | $18.1B | -22% |
| Q1 2025 | $17.9B | -22% |
| Q4 2024 | $19.4B | -21% |
| Q3 2024 | $20.6B | -16% |
BN's revenue is recovering but still below its 2023 peak: $19.3B last quarter, up 6.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 24% | +1.3 points |
| Q1 2026 | 24% | -1.1 points |
| Q4 2025 | 42% | +16 points |
| Q3 2025 | 23% | -2.9 points |
| Q2 2025 | 23% | +6.1 points |
| Q1 2025 | 25% | +8.2 points |
| Q4 2024 | 26% | +9.9 points |
| Q3 2024 | 26% | +12 points |
BN has the edge over IREN on profitability, with a higher operating margin.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over BN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
BN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$1.8B | -$1B |
| Q1 2026 | -$5.6B | -$4.5B |
| Q4 2025 | $0 | +$24.5M |
| Q3 2025 | -$919.1M | -238% |
| Q2 2025 | -$750M | +$943.6M |
| Q1 2025 | -$1.1B | +$1.5B |
| Q4 2024 | -$24.5M | +$1.2B |
| Q3 2024 | $665.5M | -48% |
BN has the edge over IREN on cash flow, with more consistent year-over-year improvement.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
BN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +0.3% | +8M shares |
| 3 years | 0% | -600K shares |
| 5 years | +1.8% | +42M shares |
| Available history | +7.3% | +162M shares |
BN has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $109.6M |
| Q1 2026 | $431.9M |
| Q4 2025 | — |
| Q3 2025 | $35.4M |
| Q2 2025 | $293.6M |
| Q1 2025 | $567.3M |
| Q4 2024 | $136.3M |
| Q3 2024 | $79.4M |
BN spent $577M buying back its own shares over the past year, down 46% from the year before.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
BN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 7.5x | High |
| Q1 2026 | 7.5x | High |
| Q4 2025 | 9.0x | High |
| Q3 2025 | 7.9x | High |
| Q2 2025 | 7.7x | High |
| Q1 2025 | 8.1x | High |
| Q4 2024 | 7.5x | High |
| Q3 2024 | 7.3x | High |
BN has the edge over IREN on leverage, with a lower net debt burden relative to earnings.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
BN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.0 | Neutral |
| Stochastic | 51.5 | Neutral |
BN's weekly RSI is 53 (neutral) and its Stochastic is 52 (neutral).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
BN PE vs Financial Services Sector
| Metric | BN | Sector median | Relative |
|---|---|---|---|
| PE | 75x | 13x | 473% above |
| PE % | 54 | 63 | 9 pts below |
BN is trading at 75x earnings, a 473% premium to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
BN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $38.5 | 8.2% above |
| 20 week MA | $40.5 | 2.8% above |
| 50 week MA | $43.0 | 3.1% below |
| 100 week MA | $41.8 | 0.4% below |
| 200 week MA | $34.2 | 22% above |
BN has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
BN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $20.7 | $21.9 | +5.6% |
| 2021 | $21.9 | $32.3 | +48% |
| 2022 | $32.3 | $21.2 | -35% |
| 2023 | $21.2 | $26.8 | +26% |
| 2024 | $26.8 | $38.1 | +43% |
| 2025 | $38.1 | $46.7 | +23% |
| 2026 YTD | $46.7 | $41.6 | -11% |
BN has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.